Vivo Capital Surplus Fund VIII, L.P., 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 650,931 shares at $15.50 ($10.1M) on 2020-04-15, disclosed to the SEC on 2020-04-17.
Open-market sale of $10.1M CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.50 | 26,185 | $406K | 4.0% |
| 2 | $15.50 | 26,185 | $406K | 4.0% |
| 3 | $15.50 | 189,625 | $2.9M | 29.2% |
| 4 | $15.50 | 189,625 | $2.9M | 29.2% |
| 5 | $15.20 | 3,663 | $56K | 0.6% |
| 6 | $15.20 | 3,663 |
| $56K |
| 0.6% |
| 7 | $15.20 | 26,527 | $403K | 4.0% |
| 8 | $15.20 | 26,527 | $403K | 4.0% |
| 9 | $15.40 | 10,265 | $158K | 1.6% |
| 10 | $15.40 | 74,333 | $1.1M | 11.4% |
| 11 | $15.40 | 74,333 | $1.1M | 11.4% |
| Total | $15.45 avg | 650,931 | $10.1M | 100% |
| Filing → |
| TERN | BUY | 2022-08-16 | $10.3M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $8.6M | — | Filing → |
| ALGS | BUY | 2020-10-20 | $8.3M | — | Filing → |